Clearbridge Health Ltd is primarily active in the healthcare industry.

The main competitors of Clearbridge Health Ltd in the market include companies such as AITbiotech Pte Ltd, Cordlife Group Limited, and Q&M Dental Group.

Clearbridge Health Ltd is a leading healthcare company with a rich history and background. Established in [year], Clearbridge Health has emerged as a trusted player in the industry, offering innovative healthcare solutions and services. The company specializes in precision medicine, providing advanced diagnostic and molecular testing, biobanking, and telemedicine services. With an extensive network of medical professionals and strategic partnerships, Clearbridge Health is committed to delivering personalized healthcare solutions to patients. Its dedication towards technological advancements, research, and quality patient care has positioned Clearbridge Health Ltd as a prominent player in the healthcare sector.

Clearbridge Health Ltd has achieved significant milestones in its growth and development. The company has expanded its presence in the healthcare industry by establishing strategic partnerships and making successful acquisitions. Clearbridge Health Ltd has also achieved notable financial milestones, demonstrating its strong performance and growth potential. Additionally, the company has received recognition for its innovative solutions and commitment to delivering high-quality healthcare services. These achievements showcase Clearbridge Health Ltd's dedication to driving positive change in the healthcare sector and establishing itself as a leading player in the industry.

Clearbridge Health Ltd is primarily present in Singapore and Malaysia.

Clearbridge Health Ltd represents a strong commitment to delivering quality healthcare solutions. The company's corporate philosophy revolves around innovation, integrity, and patient-centric care. They strive to provide advanced medical technologies and services that meet the ever-growing needs of patients and healthcare professionals. Clearbridge Health Ltd aims to improve wellness and healthcare outcomes by leveraging cutting-edge diagnostic and therapeutic solutions. Their dedication to research and development, along with strategic partnerships, allows them to stay at the forefront of the healthcare industry. By prioritizing customer satisfaction and long-term value creation, Clearbridge Health Ltd continues to establish itself as a trusted leader in the healthcare sector.

5 analysts currently rate the Clearbridge Health stock: 4 recommend buying, 1 holding and 0 selling.

Clearbridge Health Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Clearbridge Health share trades at 0,00 EUR (0,00 SGD).

Clearbridge Health Ltd is a leading company in the healthcare sector with the aim of improving the diagnosis and treatment of various diseases through the use of advanced technologies and services. The company operates in various divisions, including healthcare management, diagnosis and pathology, and medical devices. Clearbridge Health offers comprehensive services in healthcare management to meet the need for high-quality care and support. The company has developed a digital health platform that allows patients to manage their health data and communicate with doctors and medical professionals. By utilizing artificial intelligence and data analysis, Clearbridge Health has also developed a software solution to better manage medical records and make decisions. These algorithms support doctors in decision-making and aid in disease detection and prediction. In the field of diagnosis and pathology, Clearbridge Health provides a wide range of services that focus on accurate disease diagnosis. The company has developed an innovative method for detecting cancer based on sequencing tumor cells, enabling precise diagnosis. Clearbridge Health has also developed an extensive range of medical devices and is capable of supplying both clinical and home devices. These medical devices enable medical personnel to achieve fast and accurate results, facilitating quick and effective diagnoses and therapies. To improve its services and stay up to date with the latest technology, Clearbridge Health has entered into strategic partnerships with leading companies in the healthcare sector worldwide. This collaboration has helped Clearbridge Health become a market leader with its products and services. The business model of Clearbridge Health is focused on providing a comprehensive range of services and products to meet the need for high-quality care and support. The company relies on advanced technologies to achieve accurate and fast results, as well as first-class medical professionals who are able to provide optimal care to their patients. In summary, Clearbridge Health is an innovative company in the healthcare sector that contributes to improving the health and well-being of people through its use of advanced technologies and services. The company is on a growth trajectory and has already introduced a wide range of products and services tailored to the requirements of modern healthcare.

Liikevaihtoa ei voida laskea Clearbridge Health:lle tällä hetkellä.

Voittoa ei voida laskea Clearbridge Health:lle tällä hetkellä.

P/E-suhdetta ei voida laskea Clearbridge Health:lle tällä hetkellä.

P/S-suhdetta ei voida laskea Clearbridge Health:lle tällä hetkellä.

Clearbridge Health:n Eulpool-laatuscore on 3/10.

Clearbridge Health:n ISIN on SG1EB6000000. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Clearbridge Health:n WKN on A2P5MF. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Clearbridge Health:n ticker on 1H3.SI. Tämä pörssinoteeraus käytetään Clearbridge Health-osakkeiden kauppaan pörssissä.

Clearbridge Health maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Clearbridge Health kuuluu sektoriin 'Terveydenhuolto'.

Clearbridge Health:n osingot jaetaan valuutassa SGD.